Here are the most clinically significant terms and keywords extracted from the guideline, organized by category for clarity:

---

### **1. Conditions & Definitions**  
- **Hypertension**: Systolic >140 mmHg, Diastolic >90 mmHg (two occasions)  
- **Pre-existing hypertension**: Present at booking or before 20 weeks  
- **Gestational hypertension**: New-onset after 20 weeks  
- **Pre-eclampsia**: BP >140/90 + proteinuria (>20 weeks)  
- **Eclampsia**: Pre-eclampsia + seizures  
- **HELLP Syndrome**: Severe pre-eclampsia variant  
- **Superimposed pre-eclampsia**: New proteinuria/organ dysfunction in pre-existing hypertension  

### **2. Diagnostic Criteria**  
- **Proteinuria**: Key marker for pre-eclampsia  
- **Severe features**: BP ≥160/110, organ dysfunction, seizures  
- **Fetal growth restriction**: Indication for early birth  

### **3. Management Principles**  
- **Antiplatelet therapy**: Aspirin (150mg) for high-risk individuals  
- **Antihypertensives**:  
  - **First-line**: Labetalol (IV/oral)  
  - **Second-line**: Nifedipine (oral)  
  - **Third-line**: Hydralazine (IV)  
- **Magnesium sulphate**: For eclampsia/severe pre-eclampsia (avoid diazepam/phenytoin)  
- **Target BP**:  
  - Chronic hypertension: <140/90 mmHg  
  - Acute severe hypertension: <135/85 mmHg  

### **4. Timing of Birth**  
- **Before 37 weeks**: Only if BP ≥160/110, fetal growth restriction, or other indications  
- **After 37 weeks**: Shared decision with senior obstetrician  

### **5. Monitoring & Follow-up**  
- **Antenatal**:  
  - Fetal ultrasound (growth, Doppler)  
  - Cardiotocography (if indicated)  
- **Postnatal**:  
  - BP monitoring: Daily (first 2 days), then days 3–5  
  - Antihypertensive review: 2 weeks postpartum, 6–8 weeks with GP  
- **Breastfeeding**: Safe antihypertensive options  

### **6. Acute Severe Hypertension Protocol**  
- **Labetalol IV**:  
  - **Dosing**: 20mg → 